HEADER BLOOD CLOTTING 17-MAR-04 1SQ0 TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND TITLE 2 FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: VON WILLEBRAND FACTOR (VWF) [CONTAINS: VON WILLEBRAND COMPND 3 ANTIGEN II]; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: A1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PLATELET GLYCOPROTEIN IB ALPHA CHAIN (GLYCOPROTEIN IBALPHA) COMPND 9 (GP-IB ALPHA) (GPIBA) (GPIB-ALPHA) (CD42B-ALPHA) (CD42B) [CONTAINS: COMPND 10 GLYCOCALICIN]; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: GLYCOPROTEIN IB-(ALPHA); COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: VWF, F8VWF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: GP1BA; SOURCE 15 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 18 EXPRESSION_SYSTEM_CELL: CHO KEYWDS LEUCINE RICH REPEAT (LRR), RIGHT-HANDED BETA-ALPHA SUPERHELIX); KEYWDS 2 INTEGRIN A (OR I) DOMAIN FOLD, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR J.J.DUMAS,R.KUMAR,T.MCDONAGH,F.SULLIVAN,M.L.STAHL,W.S.SOMERS,L.MOSYAK REVDAT 4 27-OCT-21 1SQ0 1 SEQADV REVDAT 3 24-FEB-09 1SQ0 1 VERSN REVDAT 2 31-AUG-04 1SQ0 1 JRNL REVDAT 1 13-APR-04 1SQ0 0 JRNL AUTH J.J.DUMAS,R.KUMAR,T.MCDONAGH,F.SULLIVAN,M.L.STAHL, JRNL AUTH 2 W.S.SOMERS,L.MOSYAK JRNL TITL CRYSTAL STRUCTURE OF THE WILD-TYPE VON WILLEBRAND FACTOR JRNL TITL 2 A1-GLYCOPROTEIN IBALPHA COMPLEX REVEALS CONFORMATION JRNL TITL 3 DIFFERENCES WITH A COMPLEX BEARING VON WILLEBRAND DISEASE JRNL TITL 4 MUTATIONS JRNL REF J.BIOL.CHEM. V. 279 23327 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15039442 JRNL DOI 10.1074/JBC.M401659200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.DUMAS,R.KUMAR,J.SEEHRA,W.S.SOMERS,L.MOSYAK REMARK 1 TITL CRYSTAL STRUCTURE OF THE GPIB(ALPHA)-THROMBIN COMPLEX REMARK 1 TITL 2 ESSENTIAL FOR PLATELET AGGREGATION REMARK 1 REF SCIENCE V. 301 222 2003 REMARK 1 REFN ISSN 0036-8075 REMARK 1 DOI 10.1126/SCIENCE.1083917 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 132767.560 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 17150 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1685 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2261 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE : 0.3220 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 248 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3664 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 318 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.42000 REMARK 3 B22 (A**2) : -10.55000 REMARK 3 B33 (A**2) : 12.98000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.620 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.340 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.580 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 34.43 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DISORDERED RESIDUES IN CHAIN A INCLUDE REMARK 3 N-TERMINAL RESIDUES 496-5 AND C-TERMINAL RESIDUES 704-709. IN REMARK 3 CHAIN A, SIDE CHAIN FOR LYS IS DISORDERED. DISORDERED RESIDUES REMARK 3 IN CHAIN B INCLUDE C-TERMINAL RESIDUES 266-288. REMARK 4 REMARK 4 1SQ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-04. REMARK 100 THE DEPOSITION ID IS D_1000021902. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-AUG-02; 18-MAY-02 REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : ALS; ALS REMARK 200 BEAMLINE : 5.0.2; 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97942, 0.97959, 0.9686; 1 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111); NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4; ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17150 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 49.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD; NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELXS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG-3350; POTASSIUM THIOCYANATE, PH REMARK 280 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.24850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.05200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.24850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.05200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 GLU A 497 REMARK 465 ASP A 498 REMARK 465 ILE A 499 REMARK 465 SER A 500 REMARK 465 GLU A 501 REMARK 465 PRO A 502 REMARK 465 PRO A 503 REMARK 465 LEU A 504 REMARK 465 HIS A 505 REMARK 465 PRO A 704 REMARK 465 THR A 705 REMARK 465 LEU A 706 REMARK 465 PRO A 707 REMARK 465 PRO A 708 REMARK 465 HIS A 709 REMARK 465 THR B 266 REMARK 465 LEU B 267 REMARK 465 GLY B 268 REMARK 465 ASP B 269 REMARK 465 GLU B 270 REMARK 465 GLY B 271 REMARK 465 ASP B 272 REMARK 465 THR B 273 REMARK 465 ASP B 274 REMARK 465 LEU B 275 REMARK 465 TYR B 276 REMARK 465 ASP B 277 REMARK 465 TYR B 278 REMARK 465 TYR B 279 REMARK 465 PRO B 280 REMARK 465 GLU B 281 REMARK 465 GLU B 282 REMARK 465 ASP B 283 REMARK 465 THR B 284 REMARK 465 GLU B 285 REMARK 465 GLY B 286 REMARK 465 ASP B 287 REMARK 465 LYS B 288 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 300 O HOH B 442 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 509 146.68 -179.31 REMARK 500 ARG A 545 70.62 59.76 REMARK 500 HIS A 559 -99.43 -125.70 REMARK 500 LYS A 608 -163.73 -111.86 REMARK 500 ARG A 611 66.75 -157.81 REMARK 500 PRO A 612 9.65 -69.22 REMARK 500 ASN A 658 80.57 -57.44 REMARK 500 GLN A 686 31.07 -92.77 REMARK 500 ILE B 3 -53.86 -121.27 REMARK 500 ALA B 10 -128.13 60.80 REMARK 500 LYS B 19 62.70 38.24 REMARK 500 LEU B 42 59.21 -97.15 REMARK 500 THR B 55 5.60 -60.72 REMARK 500 CYS B 65 -152.50 -119.05 REMARK 500 LEU B 76 71.51 -118.93 REMARK 500 PRO B 77 -17.06 -45.61 REMARK 500 ASN B 87 -169.49 -126.44 REMARK 500 ASN B 110 -146.78 -126.30 REMARK 500 LEU B 123 40.12 -89.02 REMARK 500 ASN B 134 -158.16 -97.36 REMARK 500 THR B 147 69.41 -113.49 REMARK 500 ASN B 158 -161.55 -104.58 REMARK 500 ASN B 182 -160.05 -123.47 REMARK 500 ASP B 235 -4.69 75.36 REMARK 500 ASN B 242 96.03 -168.50 REMARK 500 ASP B 249 0.53 57.97 REMARK 500 ASN B 250 8.95 82.86 REMARK 500 LYS B 262 -73.52 -29.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1M10 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE REMARK 900 VON WILLEBRAND FACTOR A1 DOMAIN WITH GAIN-OF-FUNCTION MUTATIONS REMARK 900 RELATED ID: 1M0Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR BINDING DOMAIN OF REMARK 900 GLYCOPROTEIN IB ALPHA REMARK 900 RELATED ID: 1AUQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE A1 DOMAIN OF VON WILLEBRAND FACTOR REMARK 900 RELATED ID: 1P8V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB-ALPHA AND ALPHA- REMARK 900 THROMBIN REMARK 900 RELATED ID: 1OOK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB-ALPHA AND ALPHA- REMARK 900 THROMBIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 ASN RESIDUES AT POSITIONS 21 AND 159 OF CHAIN B, WHICH ARE REMARK 999 SITES FOR N-LINKED GLYCOSYLATION, WERE MUTATED TO ASP. DBREF 1SQ0 A 496 709 UNP P04275 VWF_HUMAN 1259 1472 DBREF 1SQ0 B 1 288 UNP P07359 GP1BA_HUMAN 17 304 SEQADV 1SQ0 MET A 496 UNP P04275 VAL 1259 ENGINEERED MUTATION SEQADV 1SQ0 ASP B 21 UNP P07359 ASN 37 SEE REMARK 999 SEQADV 1SQ0 ASP B 159 UNP P07359 ASN 175 SEE REMARK 999 SEQRES 1 A 214 MET GLU ASP ILE SER GLU PRO PRO LEU HIS ASP PHE TYR SEQRES 2 A 214 CYS SER ARG LEU LEU ASP LEU VAL PHE LEU LEU ASP GLY SEQRES 3 A 214 SER SER ARG LEU SER GLU ALA GLU PHE GLU VAL LEU LYS SEQRES 4 A 214 ALA PHE VAL VAL ASP MET MET GLU ARG LEU ARG ILE SER SEQRES 5 A 214 GLN LYS TRP VAL ARG VAL ALA VAL VAL GLU TYR HIS ASP SEQRES 6 A 214 GLY SER HIS ALA TYR ILE GLY LEU LYS ASP ARG LYS ARG SEQRES 7 A 214 PRO SER GLU LEU ARG ARG ILE ALA SER GLN VAL LYS TYR SEQRES 8 A 214 ALA GLY SER GLN VAL ALA SER THR SER GLU VAL LEU LYS SEQRES 9 A 214 TYR THR LEU PHE GLN ILE PHE SER LYS ILE ASP ARG PRO SEQRES 10 A 214 GLU ALA SER ARG ILE ALA LEU LEU LEU MET ALA SER GLN SEQRES 11 A 214 GLU PRO GLN ARG MET SER ARG ASN PHE VAL ARG TYR VAL SEQRES 12 A 214 GLN GLY LEU LYS LYS LYS LYS VAL ILE VAL ILE PRO VAL SEQRES 13 A 214 GLY ILE GLY PRO HIS ALA ASN LEU LYS GLN ILE ARG LEU SEQRES 14 A 214 ILE GLU LYS GLN ALA PRO GLU ASN LYS ALA PHE VAL LEU SEQRES 15 A 214 SER SER VAL ASP GLU LEU GLU GLN GLN ARG ASP GLU ILE SEQRES 16 A 214 VAL SER TYR LEU CYS ASP LEU ALA PRO GLU ALA PRO PRO SEQRES 17 A 214 PRO THR LEU PRO PRO HIS SEQRES 1 B 288 HIS PRO ILE CYS GLU VAL SER LYS VAL ALA SER HIS LEU SEQRES 2 B 288 GLU VAL ASN CYS ASP LYS ARG ASP LEU THR ALA LEU PRO SEQRES 3 B 288 PRO ASP LEU PRO LYS ASP THR THR ILE LEU HIS LEU SER SEQRES 4 B 288 GLU ASN LEU LEU TYR THR PHE SER LEU ALA THR LEU MET SEQRES 5 B 288 PRO TYR THR ARG LEU THR GLN LEU ASN LEU ASP ARG CYS SEQRES 6 B 288 GLU LEU THR LYS LEU GLN VAL ASP GLY THR LEU PRO VAL SEQRES 7 B 288 LEU GLY THR LEU ASP LEU SER HIS ASN GLN LEU GLN SER SEQRES 8 B 288 LEU PRO LEU LEU GLY GLN THR LEU PRO ALA LEU THR VAL SEQRES 9 B 288 LEU ASP VAL SER PHE ASN ARG LEU THR SER LEU PRO LEU SEQRES 10 B 288 GLY ALA LEU ARG GLY LEU GLY GLU LEU GLN GLU LEU TYR SEQRES 11 B 288 LEU LYS GLY ASN GLU LEU LYS THR LEU PRO PRO GLY LEU SEQRES 12 B 288 LEU THR PRO THR PRO LYS LEU GLU LYS LEU SER LEU ALA SEQRES 13 B 288 ASN ASN ASP LEU THR GLU LEU PRO ALA GLY LEU LEU ASN SEQRES 14 B 288 GLY LEU GLU ASN LEU ASP THR LEU LEU LEU GLN GLU ASN SEQRES 15 B 288 SER LEU TYR THR ILE PRO LYS GLY PHE PHE GLY SER HIS SEQRES 16 B 288 LEU LEU PRO PHE ALA PHE LEU HIS GLY ASN PRO TRP LEU SEQRES 17 B 288 CYS ASN CYS GLU ILE LEU TYR PHE ARG ARG TRP LEU GLN SEQRES 18 B 288 ASP ASN ALA GLU ASN VAL TYR VAL TRP LYS GLN GLY VAL SEQRES 19 B 288 ASP VAL LYS ALA MET THR SER ASN VAL ALA SER VAL GLN SEQRES 20 B 288 CYS ASP ASN SER ASP LYS PHE PRO VAL TYR LYS TYR PRO SEQRES 21 B 288 GLY LYS GLY CYS PRO THR LEU GLY ASP GLU GLY ASP THR SEQRES 22 B 288 ASP LEU TYR ASP TYR TYR PRO GLU GLU ASP THR GLU GLY SEQRES 23 B 288 ASP LYS FORMUL 3 HOH *318(H2 O) HELIX 1 1 SER A 526 LEU A 544 1 19 HELIX 2 2 ARG A 573 VAL A 584 1 12 HELIX 3 3 SER A 593 ILE A 605 1 13 HELIX 4 4 PRO A 627 SER A 631 5 5 HELIX 5 5 ASN A 633 LYS A 644 1 12 HELIX 6 6 ASN A 658 ALA A 669 1 12 HELIX 7 7 SER A 679 LEU A 683 5 5 HELIX 8 8 GLN A 686 ASP A 696 1 11 HELIX 9 9 ALA B 49 MET B 52 5 4 HELIX 10 10 ASN B 210 GLU B 212 5 3 HELIX 11 11 ILE B 213 ASN B 223 1 11 HELIX 12 12 VAL B 243 VAL B 246 5 4 HELIX 13 13 GLN B 247 SER B 251 5 5 HELIX 14 14 PRO B 255 TYR B 259 5 5 SHEET 1 A18 PHE A 675 LEU A 677 0 SHEET 2 A18 VAL A 646 ILE A 653 1 N GLY A 652 O LEU A 677 SHEET 3 A18 SER A 615 MET A 622 1 N ARG A 616 O ILE A 647 SHEET 4 A18 LEU A 513 ASP A 520 1 N VAL A 516 O ILE A 617 SHEET 5 A18 VAL A 551 TYR A 558 1 O VAL A 556 N PHE A 517 SHEET 6 A18 SER A 562 ILE A 566 -1 O HIS A 563 N GLU A 557 SHEET 7 A18 LYS B 237 SER B 241 -1 O MET B 239 N SER A 562 SHEET 8 A18 VAL B 227 GLN B 232 -1 N VAL B 229 O THR B 240 SHEET 9 A18 PHE B 199 PHE B 201 1 N ALA B 200 O TYR B 228 SHEET 10 A18 THR B 176 LEU B 178 1 N LEU B 177 O PHE B 199 SHEET 11 A18 LYS B 152 SER B 154 1 N LEU B 153 O THR B 176 SHEET 12 A18 GLU B 128 TYR B 130 1 N LEU B 129 O LYS B 152 SHEET 13 A18 VAL B 104 ASP B 106 1 N LEU B 105 O TYR B 130 SHEET 14 A18 THR B 81 ASP B 83 1 N LEU B 82 O VAL B 104 SHEET 15 A18 GLN B 59 ASN B 61 1 N LEU B 60 O THR B 81 SHEET 16 A18 ILE B 35 HIS B 37 1 N LEU B 36 O ASN B 61 SHEET 17 A18 HIS B 12 ASN B 16 1 N VAL B 15 O ILE B 35 SHEET 18 A18 GLU B 5 VAL B 9 -1 N VAL B 9 O HIS B 12 SHEET 1 B 2 THR B 45 SER B 47 0 SHEET 2 B 2 LYS B 69 GLN B 71 1 O GLN B 71 N PHE B 46 SSBOND 1 CYS A 509 CYS A 695 1555 1555 2.04 SSBOND 2 CYS B 4 CYS B 17 1555 1555 2.04 SSBOND 3 CYS B 209 CYS B 248 1555 1555 2.03 SSBOND 4 CYS B 211 CYS B 264 1555 1555 2.04 CRYST1 72.497 116.104 67.962 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013794 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008613 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014714 0.00000